Santiago Palacios

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 168 publications

Incretin-based therapies in peri- and postmenopausal women with obesity: an expert position statement from the Spanish Menopause Society.

Incretin-based therapies in peri- and postmenopausal women with obesity: an expert position statement from the Spanish Menopause Society.

Journal: Maturitas

Published: July 31, 2026

Authors' reply to L. Kiesel et al.

Authors' reply to L. Kiesel et al.

Journal: Maturitas

Published: July 15, 2026

The International Menopause Society celebrates another milestone.

The International Menopause Society celebrates another milestone.

Journal: Climacteric : the journal of the International Menopause Society

Published: July 01, 2026

From maximal weight loss to required weight loss: a call to action for weight management in gynecologic practice.

From maximal weight loss to required weight loss: a call to action for weight management in gynecologic practice.

Journal: International journal of obesity (2005)

Published: March 17, 2026

The forgotten organ in midlife women - why gynaecologists should screen for metabolic-associated fatty liver disease.

The forgotten organ in midlife women - why gynaecologists should screen for metabolic-associated fatty liver disease.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Published: February 11, 2026

Estradiol loss, the "estrobolome," and midlife symptoms: what the gut microbiome adds to menopause care.

Estradiol loss, the "estrobolome," and midlife symptoms: what the gut microbiome adds to menopause care.

Journal: Menopause (New York, N.Y.)

Published: February 02, 2026

Efficacy of a probiotic formula in the management of menopausal symptoms and quality of life: a randomized controlled trial.

Efficacy of a probiotic formula in the management of menopausal symptoms and quality of life: a randomized controlled trial.

Journal: Menopause (New York, N.Y.)

Published: January 26, 2026

Estetrol (E4) for the treatment of moderate to severe vasomotor symptoms in postmenopausal women - Efficacy and safety results from the phase 3 E4COMFORT I multicenter, placebo-controlled study.

Estetrol (E4) for the treatment of moderate to severe vasomotor symptoms in postmenopausal women - Efficacy and safety results from the phase 3 E4COMFORT I multicenter, placebo-controlled study.

Journal: Maturitas

Published: December 19, 2025

A concept for a new approach to combined oral contraception from adolescence to perimenopause: Continuous use of the oral GnRH antagonist Relugolix and the fetal estrogen Estetrol.

A concept for a new approach to combined oral contraception from adolescence to perimenopause: Continuous use of the oral GnRH antagonist Relugolix and the fetal estrogen Estetrol.

Journal: Acta obstetricia et gynecologica Scandinavica

Published: December 18, 2025

Testosterone in women: beyond hypoactive sexual desire.

Testosterone in women: beyond hypoactive sexual desire.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Published: November 30, 2025

The in vitro effects of purified and specific cytoplasmic pollen extract on dopaminergic and GABAergic systems.

The in vitro effects of purified and specific cytoplasmic pollen extract on dopaminergic and GABAergic systems.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Published: October 14, 2025

The window of opportunity for treating vulvovaginal atrophy in menopause: Insights from oestrogen receptor distribution and age-related changes.

The window of opportunity for treating vulvovaginal atrophy in menopause: Insights from oestrogen receptor distribution and age-related changes.

Journal: Maturitas

Published: October 14, 2025

Showing 1-12 of 168

Last Updated: 09/26/2026